These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
451 related articles for article (PubMed ID: 27157273)
1. Dysregulation of regulatory CD56(bright) NK cells/T cells interactions in multiple sclerosis. Laroni A; Armentani E; Kerlero de Rosbo N; Ivaldi F; Marcenaro E; Sivori S; Gandhi R; Weiner HL; Moretta A; Mancardi GL; Uccelli A J Autoimmun; 2016 Aug; 72():8-18. PubMed ID: 27157273 [TBL] [Abstract][Full Text] [Related]
2. Characterization of circulating T-, NK-, and NKT cell subsets in patients with colorectal cancer: the peripheral blood immune cell profile. Krijgsman D; de Vries NL; Skovbo A; Andersen MN; Swets M; Bastiaannet E; Vahrmeijer AL; van de Velde CJH; Heemskerk MHM; Hokland M; Kuppen PJK Cancer Immunol Immunother; 2019 Jun; 68(6):1011-1024. PubMed ID: 31053876 [TBL] [Abstract][Full Text] [Related]
3. Cytotoxicity of CD56(bright) NK cells towards autologous activated CD4+ T cells is mediated through NKG2D, LFA-1 and TRAIL and dampened via CD94/NKG2A. Nielsen N; Ødum N; Ursø B; Lanier LL; Spee P PLoS One; 2012; 7(2):e31959. PubMed ID: 22384114 [TBL] [Abstract][Full Text] [Related]
4. CD56 Wang H; Zeng Y; Zhang M; Ma H; Xu B; Jiang H; Wang J; Li G Hum Immunol; 2019 Oct; 80(10):871-877. PubMed ID: 31326139 [TBL] [Abstract][Full Text] [Related]
5. Expressions of natural cytotoxicity receptors and NKG2D on decidual natural killer cells in patients having spontaneous abortions. Zhang Y; Zhao A; Wang X; Shi G; Jin H; Lin Q Fertil Steril; 2008 Nov; 90(5):1931-7. PubMed ID: 18023431 [TBL] [Abstract][Full Text] [Related]
6. Tumor infiltrating NK cell (TINK) subsets and functional molecules in patients with breast cancer. Rezaeifard S; Talei A; Shariat M; Erfani N Mol Immunol; 2021 Aug; 136():161-167. PubMed ID: 34171565 [TBL] [Abstract][Full Text] [Related]
7. Celiac Disease-Related Inflammation Is Marked by Reduction of Nkp44/Nkp46-Double Positive Natural Killer Cells. Marafini I; Monteleone I; Di Fusco D; Sedda S; Cupi ML; Fina D; Paoluzi AO; Pallone F; Monteleone G PLoS One; 2016; 11(5):e0155103. PubMed ID: 27171408 [TBL] [Abstract][Full Text] [Related]
8. An IL-2 paradox: blocking CD25 on T cells induces IL-2-driven activation of CD56(bright) NK cells. Martin JF; Perry JS; Jakhete NR; Wang X; Bielekova B J Immunol; 2010 Jul; 185(2):1311-20. PubMed ID: 20543101 [TBL] [Abstract][Full Text] [Related]
9. Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy (daclizumab) in multiple sclerosis. Bielekova B; Catalfamo M; Reichert-Scrivner S; Packer A; Cerna M; Waldmann TA; McFarland H; Henkart PA; Martin R Proc Natl Acad Sci U S A; 2006 Apr; 103(15):5941-6. PubMed ID: 16585503 [TBL] [Abstract][Full Text] [Related]
10. Unexpected role for granzyme K in CD56bright NK cell-mediated immunoregulation of multiple sclerosis. Jiang W; Chai NR; Maric D; Bielekova B J Immunol; 2011 Jul; 187(2):781-90. PubMed ID: 21666061 [TBL] [Abstract][Full Text] [Related]
11. NK-associated receptors on CD8 T cells from treatment-naive HIV-infected individuals: defective expression of CD56. Tarazona R; DelaRosa O; Casado JG; Torre-Cisneros J; Villanueva JL; Galiani MD; Peña J; Solana R AIDS; 2002 Jan; 16(2):197-200. PubMed ID: 11807303 [TBL] [Abstract][Full Text] [Related]
12. Single-cell profiling reveals periventricular CD56 Rodríguez-Lorenzo S; van Olst L; Rodriguez-Mogeda C; Kamermans A; van der Pol SMA; Rodríguez E; Kooij G; de Vries HE Elife; 2022 May; 11():. PubMed ID: 35536009 [TBL] [Abstract][Full Text] [Related]
13. A CD8α(-) subpopulation of macaque circulatory natural killer cells can mediate both antibody-dependent and antibody-independent cytotoxic activities. Vargas-Inchaustegui DA; Demberg T; Robert-Guroff M Immunology; 2011 Nov; 134(3):326-40. PubMed ID: 21978002 [TBL] [Abstract][Full Text] [Related]
14. An unusual CD56(bright) CD16(low) NK cell subset dominates the early posttransplant period following HLA-matched hematopoietic stem cell transplantation. Dulphy N; Haas P; Busson M; Belhadj S; Peffault de Latour R; Robin M; Carmagnat M; Loiseau P; Tamouza R; Scieux C; Rabian C; Di Santo JP; Charron D; Janin A; Socié G; Toubert A J Immunol; 2008 Aug; 181(3):2227-37. PubMed ID: 18641363 [TBL] [Abstract][Full Text] [Related]
15. Characterization of the Impact of Daclizumab Beta on Circulating Natural Killer Cells by Mass Cytometry. Ranganath T; Simpson LJ; Ferreira AM; Seiler C; Vendrame E; Zhao N; Fontenot JD; Holmes S; Blish CA Front Immunol; 2020; 11():714. PubMed ID: 32391016 [TBL] [Abstract][Full Text] [Related]
16. Low-dose IL-2 induces CD56 McQuaid SL; Loughran ST; Power PA; Maguire P; Szczygiel A; Johnson PA Clin Exp Immunol; 2020 Jun; 200(3):228-241. PubMed ID: 31989589 [TBL] [Abstract][Full Text] [Related]
17. Human NK cells proliferate and die in vivo more rapidly than T cells in healthy young and elderly adults. Lutz CT; Karapetyan A; Al-Attar A; Shelton BJ; Holt KJ; Tucker JH; Presnell SR J Immunol; 2011 Apr; 186(8):4590-8. PubMed ID: 21402893 [TBL] [Abstract][Full Text] [Related]
18. NK Cells and Innate-Like T Cells After Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis. Ruder J; Rex J; Obahor S; Docampo MJ; Müller AMS; Schanz U; Jelcic I; Martin R Front Immunol; 2021; 12():794077. PubMed ID: 34975899 [TBL] [Abstract][Full Text] [Related]
19. Interferon-γ production by tubulointerstitial human CD56 Law BMP; Wilkinson R; Wang X; Kildey K; Lindner M; Rist MJ; Beagley K; Healy H; Kassianos AJ Kidney Int; 2017 Jul; 92(1):79-88. PubMed ID: 28396119 [TBL] [Abstract][Full Text] [Related]